---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-22-043051"
form_type: "8-K"
ticker: null
cik: "0001501756"
company_name: "Adverum Biotechnologies, Inc."
filed_at: "2022-11-25T23:59:59+00:00"
generated_at: "2026-06-21T13:03:22.200396+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Adverum receives Nasdaq bid-price deficiency notice; has until May 17, 2023 to comply

## Summary
- Received Nasdaq letter on Nov 18, 2022; bid price closed below $1.00 for 30 consecutive business days.
- Has 180 calendar days (until May 17, 2023) to regain compliance with minimum bid price of $1.00 for 10 consecutive business days.
- If not compliant by May 17, 2023, may be eligible for a second 180-day period if it meets other listing standards.
- Company intends to monitor bid price and evaluate options, including a potential reverse stock split.
- Currently meets all other continued listing requirements; failure to cure could lead to delisting.

## SEC filing metadata
- accession: 0001140361-22-043051
- form_type: 8-K
- cik: 0001501756
- company_name: Adverum Biotechnologies, Inc.
- filed_at: 2022-11-25T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501756/000114036122043051/0001140361-22-043051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501756/000114036122043051/brhc10044678_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-22-043051
- JSON: https://secwatch.observer/filing/0001140361-22-043051.json
- Plain text: https://secwatch.observer/filing/0001140361-22-043051.txt

## Key facts
- Listing & Compliance Notices
  Adverum Biotechnologies, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: November 18, 2022, Adverum Biotechnologies, Inc. received a letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market notifying Adverum that for the last 30 consecutive business days the bid price of Adverum’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq listing rule 5450(a)(1). The notification received has no immediate effect on the listing of Adverum’s common stock on Nasdaq. In accordance with listing rule 5810(c)(3)(A), Adverum has 180 calendar days, or until May 17, 2023, to re
  evidence_url: https://www.sec.gov/Archives/edgar/data/1501756/000114036122043051/0001140361-22-043051-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.